See the DrugPatentWatch profile for cosentyx

Based on the information available, there is no definitive evidence to suggest that Cosentyx (secukinumab) directly affects vaccine response at injection sites. However, it is important to note that immunosuppressive drugs like Cosentyx can potentially impact the immune system's response to vaccines in general [1].

Cosentyx is a medication used to treat various autoimmune conditions such as plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [1]. It works by inhibiting interleukin-17A (IL-17A), a protein that plays a key role in inflammation [1].

While there is no specific study examining the effect of Cosentyx on vaccine response at injection sites, immunosuppressive drugs like Cosentyx can affect the body's immune response to vaccines [2]. The Centers for Disease Control and Prevention (CDC) recommends that individuals on immunosuppressive therapy, including biologic agents like Cosentyx, should consult with their healthcare provider regarding the need for additional vaccine doses or adjustments to the vaccination schedule [2].

In conclusion, while there is no direct evidence that Cosentyx affects vaccine response at injection sites, immunosuppressive drugs like Cosentyx can impact the immune system's response to vaccines in general. It is essential for individuals taking Cosentyx to consult with their healthcare provider regarding vaccinations.

Sources:
[1] DrugPatentWatch.com. Cosentyx (secukinumab). <https://www.drugpatentwatch.com/drugs/cosentyx>
[2] Centers for Disease Control and Prevention. Vaccination of Persons with Weakened Immune Systems. <https://www.cdc.gov/vaccines/covid-19/info-by-product/cosentyx.html>